OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
30041659

Suzhou Sushi Testing Group Co Ltd

Industrial Machinery & EquipmentVerified

Suzhou Sushi Testing Group Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.42, indicating a relatively low reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.65, suggesting it can cover short-term obligations but with limited excess capacity. Free cash flow is modest at 54.16 million CNY, which is significantly lower than operating cash flow of 655.11 million CNY, indicating that capital expenditures are consuming a large portion of cash flow. Profitability metrics show a return on equity of 9.3% and a return on assets of 5.05%, which are in line with industry norms for industrial machinery and equipment firms. The company's gross profit margin is 41.5% (933.72 million CNY on 2.25 billion CNY revenue), and operating margin is 14.3% (321.81 million CNY), both of which are strong indicators of cost control and pricing power. Net income of 257.44 million CNY represents a 11.5% margin, further reinforcing the company's profitability relative to revenue. The company's geographic and segment exposure is not explicitly detailed in the available data, but the revenue concentration appears to be within a single primary business line, as no material segment breakdown is provided. This suggests that the company's performance is closely tied to the industrial testing and measurement equipment market, with limited diversification across product lines or regions. Looking ahead, the company is expected to maintain a stable growth trajectory, with no significant revenue acceleration or contraction indicated in the outlook. The current fiscal year is projected to show consistent performance, with no material changes in revenue or operating income expected. The absence of a detailed growth forecast suggests that the company is likely operating in a mature market with limited expansion opportunities. Risk factors include a medium liquidity risk, as the company has negative net cash after subtracting total debt, which could limit its ability to fund operations without external financing. The dilution risk is assessed as low, with no significant dilution potential from basic shares outstanding, and no adjustments to valuation have been applied to account for dilutive events. The company's capital structure remains stable, with no recent events indicating a need for equity issuance or debt restructuring. Recent events, including analyst estimates and price targets, suggest a generally positive outlook from the investment community. The mean price target of 19.39 CNY is supported by 4 strong-buy and 5 buy recommendations, with no hold or sell ratings. This indicates that analysts view the company as a potential outperformer in its sector, although the narrow range of price targets (19.07 to 19.70 CNY) suggests limited consensus on the magnitude of upside.

30-day price · 300416(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanySuzhou Sushi Testing Group Co Ltd
Ticker300416.SZ
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryIndustrial Machinery & Equipment
AI analysis

Business. Suzhou Sushi Testing Group Co Ltd operates in the industrial machinery and equipment sector, providing specialized testing and measurement solutions for industrial applications.

Classification. The company is classified under the industry "Industrial Machinery & Equipment" within the "Industrial Goods" business sector, with a confidence level of 0.92.

Suzhou Sushi Testing Group Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.42, indicating a relatively low reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.65, suggesting it can cover short-term obligations but with limited excess capacity. Free cash flow is modest at 54.16 million CNY, which is significantly lower than operating cash flow of 655.11 million CNY, indicating that capital expenditures are consuming a large portion of cash flow. Profitability metrics show a return on equity of 9.3% and a return on assets of 5.05%, which are in line with industry norms for industrial machinery and equipment firms. The company's gross profit margin is 41.5% (933.72 million CNY on 2.25 billion CNY revenue), and operating margin is 14.3% (321.81 million CNY), both of which are strong indicators of cost control and pricing power. Net income of 257.44 million CNY represents a 11.5% margin, further reinforcing the company's profitability relative to revenue. The company's geographic and segment exposure is not explicitly detailed in the available data, but the revenue concentration appears to be within a single primary business line, as no material segment breakdown is provided. This suggests that the company's performance is closely tied to the industrial testing and measurement equipment market, with limited diversification across product lines or regions. Looking ahead, the company is expected to maintain a stable growth trajectory, with no significant revenue acceleration or contraction indicated in the outlook. The current fiscal year is projected to show consistent performance, with no material changes in revenue or operating income expected. The absence of a detailed growth forecast suggests that the company is likely operating in a mature market with limited expansion opportunities. Risk factors include a medium liquidity risk, as the company has negative net cash after subtracting total debt, which could limit its ability to fund operations without external financing. The dilution risk is assessed as low, with no significant dilution potential from basic shares outstanding, and no adjustments to valuation have been applied to account for dilutive events. The company's capital structure remains stable, with no recent events indicating a need for equity issuance or debt restructuring. Recent events, including analyst estimates and price targets, suggest a generally positive outlook from the investment community. The mean price target of 19.39 CNY is supported by 4 strong-buy and 5 buy recommendations, with no hold or sell ratings. This indicates that analysts view the company as a potential outperformer in its sector, although the narrow range of price targets (19.07 to 19.70 CNY) suggests limited consensus on the magnitude of upside.
Key takeaways
  • The company maintains a conservative debt-to-equity ratio of 0.42, indicating a balanced capital structure.
  • Return on equity of 9.3% and return on assets of 5.05% suggest solid profitability relative to industry norms.
  • Free cash flow is modest at 54.16 million CNY, with capital expenditures consuming a significant portion of operating cash flow.
  • Analysts have assigned a generally positive outlook, with a mean price target of 19.39 CNY and no hold or sell ratings.
  • The company's liquidity position is assessed as medium, with a current ratio of 1.65.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$2.25B
Gross profit$933.7M
Operating income$321.8M
Net income$257.4M
R&D
SG&A
D&A
SBC
Operating cash flow$655.1M
CapEx-$359.6M
Free cash flow$54.2M
Total assets$5.10B
Total liabilities$2.33B
Total equity$2.77B
Cash & equivalents
Long-term debt$1.17B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.77B
Net cash-$1.17B
Current ratio1.6
Debt/Equity0.4
ROA5.1%
ROE9.3%
Cash conversion2.5%
CapEx/Revenue-16.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Industrial Goods · cohort 13 companies
Metric300416Activity
Op margin14.3%9.4% medp25 9.4% · p75 9.4%top quartile
Net margin11.5%5.8% medp25 5.8% · p75 5.8%top quartile
Gross margin41.5%26.9% medp25 26.9% · p75 26.9%top quartile
R&D / revenue2.0% medp25 1.6% · p75 3.0%
CapEx / revenue-16.0%2.4% medp25 1.6% · p75 3.3%bottom quartile
Debt / equity42.0%106.4% medp25 106.4% · p75 106.4%bottom quartile
Observations
IR observations
Mean price target19.39 CNY
Median price target19.39 CNY
High price target19.70 CNY
Low price target19.07 CNY
Mean recommendation1.56 (1=strong buy, 5=strong sell)
Strong-buy count4.00
Buy count5.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.67 CNY
Last actual EPS0.51 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 03:02 UTCJob: ef015cf9